Dreijerink KM - Search Results

1

The multiple endocrine neoplasia type 1 (MEN1) tumor suppressor regulates peroxisome proliferator-activated receptor gamma-dependent adipocyte differentiation.

Dreijerink KM, Varier RA, van Beekum O, Jeninga EH, Höppener JW, Lips CJ, Kummer JA, Kalkhoven E, Timmers HT. Dreijerink KM, et al. Mol Cell Biol. 2009 Sep;29(18):5060-9. doi: 10.1128/MCB.01001-08. Epub 2009 Jul 13. Mol Cell Biol. 2009. PMID: 19596783 Free PMC article.

2

A comparative study of 3D measuring methods for monitoring breast volume changes.

Dijkman BAM, Liberton NPTJ, Te Slaa S, Smit JM, Wiepjes CM, Dreijerink KMA, den Heijer M, Verdaasdonk RM, de Blok CJM. Dijkman BAM, et al. Among authors: dreijerink kma. PLoS One. 2024 Jun 6;19(6):e0305059. doi: 10.1371/journal.pone.0305059. eCollection 2024. PLoS One. 2024. PMID: 38843166 Free PMC article.

3

Tailored Gender-Affirming Hormone Treatment in Nonbinary Transgender Individuals: A Retrospective Study in a Referral Center Cohort.

van Dijken JB, Steensma TD, Wensing-Kruger SA, den Heijer M, Dreijerink KMA. van Dijken JB, et al. Transgend Health. 2023 Jun 1;8(3):220-225. doi: 10.1089/trgh.2021.0032. eCollection 2023 Jun. Transgend Health. 2023. PMID: 37342476 Free PMC article.

4

Variations in volume; Breast size in trans women in relation to timing of testosterone suppression.

Boogers LS, Sardo Infirri SA, Bouchareb A, Dijkman BAM, Helder D, de Blok CJM, Liberton NPTJ, den Heijer M, van Trotsenburg ASP, Dreijerink KMA, Wiepjes CM, Hannema SE. Boogers LS, et al. Among authors: dreijerink kma. J Clin Endocrinol Metab. 2024 Aug 16:dgae573. doi: 10.1210/clinem/dgae573. Online ahead of print. J Clin Endocrinol Metab. 2024. PMID: 39150977

5

Skin cancer incidence in transgender individuals receiving gender-affirming hormone treatment: a nationwide cohort study in the Netherlands.

Rahmat A, De Nie I, Wiepjes CM, Den Heijer M, Rustemeyer T, De Blok CJM, Dreijerink KMA. Rahmat A, et al. Int J Dermatol. 2023 Jul;62(7):882-887. doi: 10.1111/ijd.16707. Epub 2023 May 4. Int J Dermatol. 2023. PMID: 37140088

6

Patient decision aids for patients with differentiated thyroid carcinoma: development process and alpha and beta testing.

Koot A, Hermens R, Ottevanger P, Netea-Maier R, Stalmeier P; COMBO study group. Koot A, et al. Front Endocrinol (Lausanne). 2023 May 31;14:1162537. doi: 10.3389/fendo.2023.1162537. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37324263 Free PMC article.

7

[Diverse expression of multiple endocrine neoplasia type 1].

Dreijerink KM, Roijers JF, Jansen-Schillhorn van Veen JM, Neijt JP, van Vroonhoven TJ, Lips CJ. Dreijerink KM, et al. Ned Tijdschr Geneeskd. 2000 Dec 16;144(51):2437-42. Ned Tijdschr Geneeskd. 2000. PMID: 11151650 Review. Dutch.

8

[Multiple endocrine neoplasia type 1: recent developments and guidelines for DNA diagnosis and periodic clinical monitoring].

Dreijerink KM, Roijers JF, van der Luijt RB, Höppener JW, Lips CJ. Dreijerink KM, et al. Ned Tijdschr Geneeskd. 2000 Dec 16;144(51):2445-9. Ned Tijdschr Geneeskd. 2000. PMID: 11151652 Review. Dutch.

9

Acromegaly in a multiple endocrine neoplasia type 1 (MEN1) family with low penetrance of the disease.

Dreijerink KM, van Beek AP, Lentjes EG, Post JG, van der Luijt RB, Canninga-van Dijk MR, Lips CJ. Dreijerink KM, et al. Eur J Endocrinol. 2005 Dec;153(6):741-6. doi: 10.1530/eje.1.02022. Eur J Endocrinol. 2005. PMID: 16322378

10

Menin links estrogen receptor activation to histone H3K4 trimethylation.

Dreijerink KM, Mulder KW, Winkler GS, Höppener JW, Lips CJ, Timmers HT. Dreijerink KM, et al. Cancer Res. 2006 May 1;66(9):4929-35. doi: 10.1158/0008-5472.CAN-05-4461. Cancer Res. 2006. PMID: 16651450

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters